
[NEW RESOURCE] Considerations for Optimizing the COVID19 Vaccine Country Portfolio
Please find the link to an updated guidance and recommendations on COVID-19 vaccines and strategies (ENGLISH):
Considerations for optimizing the COVID-19 vaccine country portfolio (technet-21.org)
You can also find attached the FRENCH version of this this slide deck in TechNet21:
Updated in this version from January 2022 version:
-
Vaccination strategy:
-
3 reasons why COVID-19 vaccination remains a key priority in the current pandemic context
-
Update on Global COVID-19 vaccination strategy and rolling allocation
-
-
Policy guidance
-
Definition of additional booster dose and hybrid immunity
-
Update on vaccine effectiveness against Omicron
-
WHO interim statement on the use of additional booster doses of EUL mRNA vaccines (17 May 2022)
-
WHO interim statement on composition of current COVID-19 vaccines and decision-making considerations for the use of variant updated COVID-19 vaccines (June 2022)
-
-
COVID-19 vaccine product recommendation
-
Interim recommendations for use of the CanSinoBIO Ad5-nCoV-S vaccine (Convidecia ®) against COVID-19 (19 May 2022)
-
Updated WHO interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine (6 June 2022
-
